Skip to results
Modify your search
NARROW
1-20 of 59
Authors: Rafael Cantón
Journal Article
Cefiderocol AST in a real-life Klebsiella pneumoniae collection: challenges in the ATU range Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 797–801, https://doi.org/10.1093/jac/dkae477
Published: 15 January 2025
Journal Article
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study Open Access
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2132–2141, https://doi.org/10.1093/jac/dkae157
Published: 11 July 2024
Journal Article
In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain Free
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 6, June 2024, Pages 1432–1440, https://doi.org/10.1093/jac/dkae126
Published: 06 May 2024
Journal Article
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project) Free
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2291–2296, https://doi.org/10.1093/jac/dkad234
Published: 03 August 2023
Journal Article
Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain Free
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 5, May 2023, Pages 1259–1264, https://doi.org/10.1093/jac/dkad086
Published: 25 March 2023
Journal Article
Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022 Open Access
Journal of Antimicrobial Chemotherapy, Volume 77, Issue Supplement_1, September 2022, Pages i2–i9, https://doi.org/10.1093/jac/dkac211
Published: 06 September 2022
Journal Article
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies) Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3163–3172, https://doi.org/10.1093/jac/dkac298
Published: 05 September 2022
Journal Article
Hidden dissemination of carbapenem-susceptible OXA-48-producing Proteus mirabilis Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3009–3015, https://doi.org/10.1093/jac/dkac267
Published: 16 August 2022
Journal Article
EDITOR'S CHOICE
Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 10, October 2021, Pages 2578–2585, https://doi.org/10.1093/jac/dkab222
Published: 20 July 2021
Journal Article
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening Open Access
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 4, April 2021, Pages 1001–1009, https://doi.org/10.1093/jac/dkaa543
Published: 14 January 2021
Journal Article
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 4, April 2021, Pages 984–992, https://doi.org/10.1093/jac/dkaa529
Published: 24 December 2020
Journal Article
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 2, February 2021, Pages 370–379, https://doi.org/10.1093/jac/dkaa430
Published: 25 October 2020
Journal Article
Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016–18) Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 1, January 2021, Pages 110–116, https://doi.org/10.1093/jac/dkaa398
Published: 07 October 2020
Journal Article
Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones Free
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 11, November 2018, Pages 3039–3043, https://doi.org/10.1093/jac/dky284
Published: 24 July 2018
Journal Article
MIC-based dose adjustment: facts and fables—authors’ response Free
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 9, September 2018, Pages 2585–2586, https://doi.org/10.1093/jac/dky195
Published: 21 June 2018
Journal Article
MIC-based dose adjustment: facts and fables Free
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 3, March 2018, Pages 564–568, https://doi.org/10.1093/jac/dkx427
Published: 05 December 2017
Journal Article
Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 5, May 2017, Pages 1421–1428, https://doi.org/10.1093/jac/dkx001
Published: 31 January 2017
Journal Article
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 5, May 2017, Pages 1478–1487, https://doi.org/10.1093/jac/dkw562
Published: 15 January 2017
Journal Article
Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study Open Access
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 431–436, https://doi.org/10.1093/jac/dkw442
Published: 20 October 2016
Journal Article
Long-term clonal dynamics of Enterococcus faecium strains causing bloodstream infections (1995–2015) in Spain Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 48–55, https://doi.org/10.1093/jac/dkw366
Published: 21 September 2016
